The immune checkpoint gene CXCL1 shows statistically significant differences between subtype A (Cluster 1) and subtype B (Cluster 2) in cervical cancer (CESC) samples (p value < 0.001) (Figure 6A). Here, CXCL1 is linked to cervical cancer.